Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abiomed Inc
(NQ:
ABMD
)
381.02
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abiomed Inc
< Previous
1
2
3
Next >
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
April 05, 2022
With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks.
Via
InvestorPlace
Abiomed's Return On Capital Employed Insights
February 04, 2022
According to Benzinga Pro data Abiomed (NASDAQ:ABMD) posted a 19.67% decrease in earnings from Q2. Sales, however, increased by 5.25% over the previous quarter to $261.18 million.
Via
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Abiomed Q3 Earnings
February 03, 2022
Abiomed (NASDAQ:ABMD) reported its Q3 earnings results on Thursday, February 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.
Via
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
Via
Benzinga
Ominous Death Cross Forms On Abiomed's Chart
January 25, 2022
If history is any guide, there may be trouble ahead for shares of Abiomed (NASDAQ:ABMD). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 10, 2022
Gainers Inari Medical (NASDAQ:NARI) stock...
Via
Benzinga
ABIOMED, inc (ABMD) Q2 2022 Earnings Call Transcript
October 28, 2021
ABMD earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abiomed's Earnings Outlook
October 27, 2021
Abiomed (NASDAQ:ABMD) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Smallest Heart Pump From Abiomed Gets FDA Breakthrough Device Tag
August 18, 2021
The FDA has granted breakthrough device designation to Abiomed Inc's (NASDAQ: ABMD) Impella ECP expandable percutaneous heart pump. Abiomed designed the...
Via
Benzinga
Exposures
Product Safety
ABIOMED, inc (ABMD) Q1 2022 Earnings Call Transcript
August 05, 2021
ABMD earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021
June 18, 2021
Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE:
Via
Benzinga
Avoid the Dogecoin Crash by Buying These 2 Growth Stocks Instead
May 11, 2021
Dogecoin may be breaking its all-time highs every other day, but there's nothing averting a catastrophic fall.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
Abiomed to Shareholders: Patience Please, Growth Is On The Way.
May 04, 2021
Despite record revenue for its latest quarter, the medical device maker's shares sank 8% following its earnings release. But its next stage of growth is coming.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript
April 29, 2021
ABMD earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.